These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34132674)

  • 1. Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor.
    Cheng Z; Zou S; Cheng S; Song S; Zhu X
    Clin Nucl Med; 2021 Sep; 46(9):764-765. PubMed ID: 34132674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Imaging of Pancreatic Cancer With Liver Metastases.
    Deng M; Chen Y; Cai L
    Clin Nucl Med; 2021 Jul; 46(7):589-591. PubMed ID: 33630809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types.
    Çermik TF; Ergül N; Yılmaz B; Mercanoğlu G
    Clin Nucl Med; 2022 Apr; 47(4):e333-e339. PubMed ID: 35085165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 68Ga-FAPI PET/CT Versus 68Ga-DOTATATE PET/CT in the Evaluation of a Patient With Neuroendocrine Tumor.
    Kömek H; Gündoğan C; Can C
    Clin Nucl Med; 2021 May; 46(5):e290-e292. PubMed ID: 33351508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinoma.
    Gündoğan C; Kömek H; Can C; Yildirim ÖA; Kaplan İ; Erdur E; Poyraz K; Güzel Y; Oruç Z; Çakabay B
    Nucl Med Commun; 2022 Jan; 43(1):64-72. PubMed ID: 34661379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG.
    Shu Q; Deng M; Hu M; Liu M; Chen X; Chen Y; Cai L
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1442-1452. PubMed ID: 36609606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.
    Xie F; Fu L; Zhou W
    Clin Nucl Med; 2022 Dec; 47(12):e758-e759. PubMed ID: 36342807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the diagnostic efficacy of
    Zhang Z; Jia G; Pan G; Cao K; Yang Q; Meng H; Yang J; Zhang L; Wang T; Cheng C; Zuo C
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2877-2888. PubMed ID: 35243518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 18F-FDG and 68Ga-FAPI PET/CT in Gastric Kaposi Sarcoma.
    Tatar G; Beyhan E; Erol Fenercioğlu Ö; Arslan E; Çermik TF
    Clin Nucl Med; 2022 Sep; 47(9):e596-e599. PubMed ID: 35930714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor.
    Chan M; Schembri GP
    Clin Nucl Med; 2017 Feb; 42(2):108-109. PubMed ID: 27997429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68Ga-FAPI PET/CT Imaging of Multiple Muscle Metastases of Pancreatic Cancer.
    Gong W; Yang X; Wu J; Ou L; Zhang C
    Clin Nucl Med; 2022 Jan; 47(1):73-75. PubMed ID: 34874351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT and 68Ga-FAPI-4 PET/CT Findings of Bilateral Knee Osteoarthritis in a Patient With Uveal Malignant Melanoma.
    Erol Fenercioğlu Ö; Beyhan E; Ergül N; Arslan E; Çermik TF
    Clin Nucl Med; 2022 Feb; 47(2):e144-e146. PubMed ID: 34319962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 68Ga-FAPI and 18F-PET/CT Images in Intestinal Tuberculosis.
    Zheng J; Lin K; Zheng S; Yao S; Miao W
    Clin Nucl Med; 2022 Mar; 47(3):239-240. PubMed ID: 34619704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Adult Pancreatoblastoma by 18F-FDG and 68Ga-DOTATATE PET/MR.
    Zhou J; Xie J; Pan Y; Zhang Y
    Clin Nucl Med; 2021 Aug; 46(8):671-674. PubMed ID: 33661203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
    Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
    J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience.
    Elboga U; Sahin E; Cayirli YB; Okuyan M; Aktas G; Haydaroglu Sahin H; Dogan I; Kus T; Akkurd DM; Cimen U; Mumcu V; Kilbas B; Celen YZ
    Tomography; 2022 Feb; 8(1):293-302. PubMed ID: 35202189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Combined Interpretation of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Classification System With Prognostic Impact.
    Hayes AR; Furtado O'Mahony L; Quigley AM; Gnanasegaran G; Caplin ME; Navalkissoor S; Toumpanakis C
    Clin Nucl Med; 2022 Jan; 47(1):26-35. PubMed ID: 34874347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The added value of [
    Liu Q; Shi S; Liu S; Xu X; Hu S; Zhang J; Wang C; Yu X; Song S
    Eur Radiol; 2023 Jul; 33(7):5007-5016. PubMed ID: 36809431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography and computed tomography with [
    Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 177Lu-FAPI Therapy in a Patient With End-Stage Metastatic Pancreatic Adenocarcinoma.
    Kaghazchi F; Aghdam RA; Haghighi S; Vali R; Adinehpour Z
    Clin Nucl Med; 2022 Mar; 47(3):e243-e245. PubMed ID: 35025800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.